Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rosacea Radiofrequency Microneedling

NCT: NCT06801717 · RECRUITING

NCT IDNCT06801717
StatusRECRUITING
Start Date2024-11-01
Completion2026-07-01

Brief Summary

There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.

Frequently Asked Questions

What is Rosacea Radiofrequency Microneedling?

Rosacea Radiofrequency Microneedling is a clinical trial registered under NCT06801717. Current status: RECRUITING.

What is the status of NCT06801717?

The current status of NCT06801717 (Rosacea Radiofrequency Microneedling) is: RECRUITING.

When did Rosacea Radiofrequency Microneedling start?

Rosacea Radiofrequency Microneedling started on 2024-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.